Novel tocotrienols of rice bran inhibit atherosclerotic lesions in C57BL/6 apoE-deficient mice

被引:66
作者
Qureshi, AA [1 ]
Salser, WA
Parmar, R
Emeson, EE
机构
[1] Adv Med Res, Madison, WI 53719 USA
[2] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90024 USA
[3] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA
[4] Univ Illinois, Coll Med, Dept Pathol, Chicago, IL 60612 USA
关键词
C57BL/6 apoE-deficient (-/-) mice; novel tocotrienols (TRF25; d-P-25-T3); atherosclerotic lesions; serum cholesterol; triglycerides;
D O I
10.1093/jn/131.10.2606
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
We are studying novel tocotrienols, which have a number of activities that might interfere with the formation of atherosclerotic placques, including hypocholesterolemic, antioxidant, anti-inflammatory and antiproliferation effects. This study compared the effects of alpha-tocopherol, the tocotrienol-rich fraction (TRF25) and didesmethyl tocotrienol (d-P-25-T3) of rice bran on the pathogenesis of atherosclerotic lesions in C57BL/6 apolipoprotein (apo)E-deficient (-/-) mice. These mice are an excellent model because they become hyperlipidemic even when they consume a low fat diet and they develop complex atherosclerotic lesions similar to those of humans. These compounds were also tested in wild-type C57BL/6 apoE (+/+) and (+/-) mice fed low or high fat diets. When a high fat diet was supplemented with alpha -tocopherol, TRF25 or d-P-25-T3 and fed to mice (+/+) for 24 wk, atherosclerotic lesion size was reduced 23% (P = 0.33), 36% (P = 0.14) and 57% (P < 0.02), respectively, and in mice (+/-) fed for 18 wk, lesions were reduced by 19% (P = 0.15), 28% (P < 0.01) and 33% (P < 0.005), respectively, compared with mice fed a control diet. A low fat diet did not cause atherosclerotic lesions in these mice. The low fat diet supplemented with TRF25 or d-P25-T3 fed to apoE-deficient (-/-) mice for 14 wk decreased atherosclerotic lesion size by 42% (P < 0.04) and 47% (P < 0.01), respectively, whereas alpha -tocopherol supplementation resulted in only an 11% (P = 0.62) reduction. These results demonstrate the superior efficacy of tocotrienols compared with alpha -tocopherol. Although tocotrienols decreased serum triglycerides, total and LDL cholesterol levels, the decreases in atherosclerotic lesions seem to be due to the other activities. Serum tocol concentrations in various groups are also described. This is the first report of a significant reduction in the atherosclerotic lesion size in all three genotypes of apoE mice fed a novel tocotrienol (d-P-25-T3) of rice bran. Dietary tocotrienol supplements may provide a unique approach to promoting cardiovascular health.
引用
收藏
页码:2606 / 2618
页数:13
相关论文
共 71 条
  • [1] Aherne W, 1982, MORPHOMETRY
  • [2] VITAMIN-E - A SENSOR AND AN INFORMATION TRANSDUCER OF THE CELL OXIDATION-STATE
    AZZI, A
    BOSCOBOINIK, D
    MARILLEY, D
    OZER, NK
    STAUBLE, B
    TASINATO, A
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 1995, 62 (06) : 1337 - 1346
  • [3] Nonantioxidant functions of α-tocopherol in smooth muscle cells
    Azzi, A
    Breyer, I
    Feher, M
    Ricciarelli, R
    Stocker, A
    Zimmer, S
    Zingg, JM
    [J]. JOURNAL OF NUTRITION, 2001, 131 (02) : 378S - 381S
  • [4] ATHEROSCLEROSIS - BASIC MECHANISMS - OXIDATION, INFLAMMATION, AND GENETICS
    BERLINER, JA
    NAVAB, M
    FOGELMAN, AM
    FRANK, JS
    DEMER, LL
    EDWARDS, PA
    WATSON, AD
    LUSIS, AJ
    [J]. CIRCULATION, 1995, 91 (09) : 2488 - 2496
  • [5] ALPHA-TOCOPHEROL (VITAMIN-E) REGULATES VASCULAR SMOOTH-MUSCLE CELL-PROLIFERATION AND PROTEIN-KINASE-C ACTIVITY
    BOSCOBOINIK, D
    SZEWCZYK, A
    AZZI, A
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1991, 286 (01) : 264 - 269
  • [6] BOSCOBOINIK D, 1991, J BIOL CHEM, V266, P6188
  • [7] Lovastatin maintains nitric oxide -: but not EDHF-mediated endothelium-dependent relaxation in the hypercholesterolemic rabbit carotid artery
    Brandes, RP
    Behra, A
    Lebherz, C
    Böger, RH
    Bode-Böger, SM
    Mügge, A
    [J]. ATHEROSCLEROSIS, 1999, 142 (01) : 97 - 104
  • [8] Brown AJ, 2000, J LIPID RES, V41, P226
  • [9] BURTON GW, 1988, HDB FREE RADICALS AN, V2, P29